Home/Filings/4/0001062993-24-010453
4//SEC Filing

Spandow Oliver J. 4

Accession 0001062993-24-010453

CIK 0001196298other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 4:25 PM ET

Size

13.4 KB

Accession

0001062993-24-010453

Insider Transaction Report

Form 4
Period: 2024-05-14
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-05-14+7,3237,323 total
    Exercise: $2.14Exp: 2034-05-14Common Stock (7,323 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $5.58Exp: 2028-08-10Common Stock (9,466 underlying)
    9,466
  • Stock Option (Right to Buy)

    Exercise: $8.57Exp: 2029-12-16Common Stock (5,568 underlying)
    5,568
  • Stock Option (Right to Buy)

    Exercise: $8.06Exp: 2031-01-06Common Stock (6,850 underlying)
    6,850
  • Stock Option (Right to Buy)

    Exercise: $6.82Exp: 2031-12-14Common Stock (7,062 underlying)
    7,062
  • Stock Option (Right to Buy)

    Exercise: $1.07Exp: 2033-01-05Common Stock (7,080 underlying)
    7,080
  • Common Stock

    81,604
  • Stock Option (Right to Buy)

    Exercise: $5.85Exp: 2028-12-19Common Stock (5,161 underlying)
    5,161
Footnotes (3)
  • [F1]Fully exercisable.
  • [F2]This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25.
  • [F3]Represents options granted to the reporting person for his service on the Company's Board of Directors for 2023. This option vests as to 2,441 shares on each of 5/14/24, 5/14/25 and 5/14/26.

Issuer

NEPHROS INC

CIK 0001196298

Entity typeother

Related Parties

1
  • filerCIK 0001749836

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:25 PM ET
Size
13.4 KB